Showing results (181-190 of 468) with videos related to

Sort By:
Pageof 47
Cancer|March 2, 2005
Estimated impact of the Prostate Cancer Prevention Trial on population mortalityJoseph M Unger, Ian M Thompson, Michael LeBlanc, et al.
The Journal of Urology|July 12, 2005
The modulation of prostate cancer risk with alpha-tocopherol: a pilot randomized, controlled clinical trialJavier Hernáandez, Samira Syed, Geoffrey Weiss, et al.
The Prostate|May 29, 2009
Serum adiponectin, C-peptide and leptin and risk of symptomatic benign prostatic hyperplasia: results from the Prostate Cancer Prevention TrialJeannette M Schenk, Alan R Kristal, Marian L Neuhouser, et al.
The Journal of Urology|August 12, 2005
Long-term effects of finasteride on prostate specific antigen levels: results from the prostate cancer prevention trialRuth D Etzioni, Nadia Howlader, Pamela A Shaw, et al.
American Journal of Epidemiology|July 2, 2013
Should modest elevations in prostate-specific antigen, International Prostate Symptom Score, or their rates of increase over time be used as surrogate measures of incident benign prostatic hyperplasia?Jeannette M Schenk, Rachel Hunter-Merrill, Yingye Zheng, et al.
American Journal of Epidemiology|February 12, 2008
Dietary patterns, supplement use, and the risk of symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trialAlan R Kristal, Kathryn B Arnold, Jeannette M Schenk, et al.
Medical Hypotheses|August 6, 2018
mTOR inhibitors for treatment of low-risk prostate cancerMichael A Liss, Lanette Rickborn, John DiGiovanni, et al.
American Journal of Epidemiology|July 5, 2012
Indications for and use of nonsteroidal antiinflammatory drugs and the risk of incident, symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trialJeannette M Schenk, Gregory S Calip, Catherine M Tangen, et al.
European Urology|July 16, 2018
Metabolic Biosynthesis Pathways Identified from Fecal Microbiome Associated with Prostate CancerMichael A Liss, James Robert White, Martin Goros, et al.
The Journal of Urology|June 14, 2008
[-2]proenzyme prostate specific antigen for prostate cancer detection: a national cancer institute early detection research network validation studyLori J Sokoll, Yinghui Wang, Ziding Feng, et al.
Pageof 47